Skip to product information
1 of 1
HPLC-Verified > 99%

FOXO4-DRI

FOXO4-DRI

Lyophilized Peptide • Research Grade
Regular price $99.00 USD
Regular price Sale price $99.00 USD
Sale Sold out
Volume
Quantity

Certificate of Analysis

Third Party Tested

TLDR

TL;DR:

A D-retro-inverso peptide used to investigate FOXO4–p53 interaction disruption and selective clearance of senescent cell populations in vitro.

Description

Product Description
FOXO4-DRI is a D-retro-inverso peptide designed to disrupt FOXO4–p53 interaction, supplied as ≥98% pure lyophilized material for senescent-cell research.

Key Research Mechanism
Competitive interference with FOXO4–p53 binding is used to study p53-dependent clearance of senescent cell populations and related SASP signaling in vitro.

Primary Research Areas

  • Senolytic mechanism studies
  • FOXO4–p53 interaction assays
  • Cellular senescence models

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.

Shipping & Returns

Orders placed by 3PM will ship same day. All orders placed after 3PM will ship next business day.

Injectables are Non-returnable items
Certain types of items cannot be returned, like perishable goods (such as food, flowers, or plants), custom products (such as special orders or personalized items), and personal care goods (such as beauty products, supplements, and injectables). We also do not accept returns for hazardous materials, flammable liquids, or gases.

Please get in touch if you have questions or concerns about the quality of your specific item and we will work on resolution.

View full details

Certificate of Analysis

Third Party Tested

Molecular Profile

A D-retro-inverso peptide used to investigate FOXO4–p53 interaction disruption and selective clearance of senescent cell populations in vitro.

Compound FOXO4-DRI
Batch # 20260605
Formula C228H388N86O64
Mol Wt 5358 g/mol
CAS 2460055-10-9
latest ISO 17025 8× Testing

99.80%

Purity
VariantFOXO4-DRI
COA ##13798
Labeled5mg
Validation KeyAXISBIOTECH
Tested08/25/26
Full QC Panel - 8× tested ✓
Purity (HPLC) - 99.80% ✓
Net Peptide Content - 5mg ✓
Identity (HPLC) - FOXO4-DRI ✓
Fentanyl Screen - Not Detected ✓
HPLC Conformity mean - >99% ✓
ISO/IEC 17025 Accredited
Storage Requirements

Stability Information

Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder) −20°C long-term
2–8°C
Reconstituted Recommended condition
Light protection Store away from light

Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.

Certificate of Analysis

Precision Synthesis

Developed in collaboration with leading US-based scientific facilities to push the boundaries of biochemical research.

Explore Research Blog

Safety & Regulatory Compliance Warning

These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.